Non-depleting CD4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (IDDM)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5670150
SERIAL NO

08436843

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Non-depleting CD4 monoclonal antibodies may be used in the treatment of insulin-dependent diabetes mellitus.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE TOLERX INC LIQUIDATING TRUST14114 CHINKAPIN DRIVE ROCKVILLE MD 20850

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cooke, Anne Cambridge, GB 1 0
Waldmann, Herman Cambridge, GB 47 1173

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation